News & Analysis on Clinical Trial Services & Contract Research And Development
Alnylam has been issued a US patent, which protects its method of making small interfering RNAs with and without chemical modifications, which is set to have far reaching implications in future drug discovery.
According to the results of a new survey HIV patients are in the dark about treatment options and the significance of drug resistance, not only jeopardising their own health but also potentially exacerbating the problem of limited treatment options.
A team of scientists believe that a worm can help to discover new drugs by genetically modification allowing the worm to distinguish harmful chemicals to those with therapeutic benefit.